Gyre Therapeutics Inc.
GYRE
$6.77-1.38%
Delayed · as of Oct 13, 2026, 2:00 PM ET
Mkt cap
$589.93M
EV/Sales
4.74
P/E ratio
N/A
FY2025 Revenue
$116.59M
EPS (H1 2026)
$-0.26
Gross Margin (FY2025)
95.35%
Profit Margin (FY2025)
8.47%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Gyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
Latest reported GYRE revenue for 2025-12-31 was $116.6M. Net income was $9.9M. Revenue was up 10.2% from 2024-12-31 to 2025-12-31. GYRE currently screens at market cap $589.9M.
Use this GYRE research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full GYRE income, balance, and cash tables.
Gyre Therapeutics Inc. (GYRE) is a biotechnology company in the Healthcare sector.
Latest cached Gyre Therapeutics Inc. (GYRE) revenue for Dec 31, 2025 was $116.6M. Net income was $9.9M. Statements: https://lician.com/financials/gyre
Gyre Therapeutics Inc. (GYRE) market capitalization is $589.9M on the latest cached snapshot.
Gyre Therapeutics Inc. (GYRE) cached previous close $6.87; day range $6.77 – $6.89; volume 37,897. Session quote: https://lician.com/quote/gyre
Gyre Therapeutics Inc. (GYRE) latest cached earnings event is "GYRE earnings" on Aug 10, 2026. Earnings calendar: https://lician.com/earnings
The latest cached GYRE filing is 8-K · Sep 1, 2026. Filings: https://lician.com/sec/gyre